None listed
Conditions
Brief summary
This study aims to determine whether the smartphone applications for skin screening are effective at providing an accurate diagnosis of melanoma. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have a suspected melanoma and/or clinically benign skin lesion. Study details. The accuracy of smartphone applications will be tested by taking photos of the skin lesions and comparing the smartphone applications evaluation against the histological gold standard diagnosis by a dermatologist. If the study shows that these applications are accurate, this will allow greater acceptance of them for medical use. If inaccurate, it will raise concerns about the need for regulation of these applications due to the health risk posed.
Interventions
Study of the efficacy of use of Dr Mole, Skinvision and Spotmole Plus smartphone applications in the self diagnosis of melanoma from images of naevi. Photos of naevi will be taken by smartphones. A dermatology consultation will determine if lesions are suspicious or benign. For patients with suspicious lesions, photos will be taken prior to the traditional dermatological intervention involving excision of the lesion. The smartphone photo's will be submitted to each of the smartphone applicat
Study of the efficacy of use of Dr Mole, Skinvision and Spotmole Plus smartphone applications in the self diagnosis of melanoma from images of naevi. Photos of naevi will be taken by smartphones. A dermatology consultation will determine if lesions are suspicious or benign. For patients with suspicious lesions, photos will be taken prior to the traditional dermatological intervention involving excision of the lesion. The smartphone photo's will be submitted to each of the smartphone applications for evaluation. The smartphone application evaluations will then be compared to the histo-pathological report and dermatologist diagnosis for suspect lesions, and to the dermatologist diagnosis for benign lesions (as no histo-pathological diagnosis will be available for benign lesions).
Sponsors
Dermatology Research Centre, School of Medicine, University of Queensland
Study design
Allocation
Non-randomised trial
Primary purpose
Diagnosis
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients with suspected melanoma and/or clinically benign lesions
Exclusion criteria
No suspected melanoma or clinically benign lesions
Outcome results
None listed